Home » Topics » Regulatory

Regulatory
RSS

FDA approves Isentress pediatric oral suspension

Jan. 10, 2014

FDA approves Orenitram for PAH

Dec. 24, 2013

FDA approves Sovaldi for chronic hepatitis C

Dec. 9, 2013

FDA approves Xiaflex for Peyronie's disease

Dec. 9, 2013

Daiichi Sankyo launches new formulation of natural tetrahydrobiopterin agent

Dec. 2, 2013

FDA approves Varithena for the treatment of patients with incompetent veins

Nov. 28, 2013

FDA approves Velphoro to treat hyperphosphatemia in patients with CKD on dialysis

Nov. 28, 2013

FDA approves Nexavar for thyroid cancer

Nov. 25, 2013

Onoact 50 approved in Japan for new indication

Nov. 22, 2013

European approval of Kineret for CAPS

Nov. 21, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...